China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE000000Q94
China Resources Double-Crane Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 11.21 bn CNY | 11.00 bn CNY |
| Gross profit | 6.38 bn CNY | 6.38 bn CNY |
| Operating income | 1.83 bn CNY | 1.86 bn CNY |
| EBIT | 1.88 bn CNY | 1.94 bn CNY |
| Net income | 1.63 bn CNY | 1.65 bn CNY |
| Diluted EPS – continuing operations | 1.58 CNY | 1.59 CNY |
Full history since 1994, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About China Resources Double-Crane Pharmaceutical Co Ltd
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.
More stocks
- TOOTSIE ROLL INDUSTRIES INC (TR)
- Cementos Molins SA (CMO.MC)
- Zhuhai Bojay Electronics Co Ltd (002975.SZ)
- Shanghai Beite Technology Co (603009.SS)
- Bloomage Biotechnology Corp Ltd (688363.SS)
- Hypera SA (HYPMY)
- StoneCo Ltd (STNE)
- Cyfrowy Polsat SA (CPS.WA)
- Guizhou Chanhen Chemical Corp (002895.SZ)
- CMC Markets PLC (CMCX.L)
- Jenoptik (JEN.DE)
- Shanghai Haoyuan Chemexpress Co. Ltd. A (688131.SS)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.